BIM
LABU icon

Bullseye Investment Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bullseye Investment Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,640
Closed -$1.9M – 60
2021
Q4 		$1.9M Buy
+2,640
New +$2.53M 1.38% 27

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Bullseye Investment Management's LABU Position: Q1 2022 in Review

Bullseye Investment Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2022, closing a stake of 2,640 shares — an estimated $1.9M sold.

Bullseye Investment Management first reported a position in LABU in Q4 2021 and held it in 1 quarter. The position peaked at $1.9M in Q4 2021. 32 funds tracked by Wall St. Rank hold LABU as of Q1 2022.

  • Bullseye Investment Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2022 after selling out during the quarter.
  • Bullseye Investment Management sold 2,640 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2022, an estimated $1.9M.
  • Bullseye Investment Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2021 and held it in 1 quarter.
  • Bullseye Investment Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.9M in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2022.

Based on Bullseye Investment Management's 13F filing for Q1 2022, filed 20 Apr 2022.